RS2168101 LMO1
Upload your DNA to see your genotype for this variant.
What This Variant Does
"Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism: SNP rs216810...
Associated Conditions
LMO1 POLYMORPHISM
Neuroblastoma
susceptibility to
7
LMO1 POLYMORPHISM
Neuroblastoma
susceptibility to
7
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Glutamine levels | A | β: 0.07 | 2E-208 | PubMed |
| Alanine levels | A | β: 0.06 | 2E-151 | PubMed |
| Glutamine levels | C | β: 0.067 | 2E-48 | PubMed |
| Glutamine levels | C | β: 0.066 | 3E-46 | PubMed |
| Glycine levels | A | β: 0.03 | 3E-43 | PubMed |
| Fasting blood glucose | A | β: 0.024 | 2E-42 | PubMed |
| Tyrosine levels | A | β: 0.03 | 2E-40 | PubMed |
| Height (maximum, inv-normal transformed) | C | β: 0.042 | 5E-37 | PubMed |
| Glutamine levels | A | β: 0.059 | 1E-35 | PubMed |
| Glutamine levels (UKB data field 23461) | A | β: 0.063 | 4E-33 | PubMed |
| height (mean, inv-normal transformed) | C | β: 0.039 | 9E-33 | PubMed |
| Alanine levels | C | β: 0.053 | 1E-30 | PubMed |
| Alanine levels | C | β: 0.052 | 1E-29 | PubMed |
| Alanine levels (UKB data field 23460) | A | β: 0.05 | 7E-27 | PubMed |
| height (minimum, inv-normal transformed) | C | β: 0.033 | 1E-24 | PubMed |
| Albumin levels | A | β: 0.019 | 2E-24 | PubMed |
| Histidine levels | A | β: 0.02 | 5E-23 | PubMed |
| Total concentration of branched-chain amino acids (leucine + isoleucine + valine) | A | β: 0.02 | 2E-22 | PubMed |
| Valine levels | A | β: 0.02 | 6E-22 | PubMed |
| Leucine levels | A | β: 0.02 | 1E-21 | PubMed |